
Race Oncology doses first patient in RC220 Phase 1 solid tumour trial
The first of up to 32 patients has been safely dosed in RAC’s Phase 1 clinical trial assessing RC220 in solid tumours. Pic: Getty Images. First patient dosed at lead trial site, Southside Cancer Care. Phase 1 trial to determine safety, tolerability and …